study...Your post covers most of the salient points about Amarin's current situation...but as I reflect on it, it omits mention of MND-2119 products and fixed dose combo drugs, especially using MND-2119 with statins..., which could be game changers in 3 to 5 years...For those willing to wait that long, it could still turn out to be be a successful investment.
Market Data 
Markets 
AI
